GLP-1 Agonists Market: Driving Innovation and Growth in Metabolic...

added blog Health

2025-12-05 08:30:15 -

GLP-1 Agonists Market: Driving Innovation and Growth in Metabolic and Cardiovascular Care

The global GLP-1 agonists market is on a steep growth trajectory, driven by the surging prevalence of metabolic disorders such as obesity and type 2 diabetes (T2D), along with expanding indications into cardiovascular and other chronic diseases. Valued at approximately USD 64.42 billion in 2025, the market is forecast to reach a staggering USD 170.75 billion by 2033, growing...

0 Comments 0 Shares 59 Views 0 Reviews